CSPC PHARMACEUTGR (Germany) Performance
| CVGU Stock | EUR 2.22 0.04 1.83% |
On a scale of 0 to 100, CSPC PHARMACEUTGR holds a performance score of 4. The firm shows a Beta (market volatility) of 0.9, which signifies possible diversification benefits within a given portfolio. CSPC PHARMACEUTGR returns are very sensitive to returns on the market. As the market goes up or down, CSPC PHARMACEUTGR is expected to follow. Please check CSPC PHARMACEUTGR's information ratio, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether CSPC PHARMACEUTGR's price patterns will revert.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in CSPC PHARMACEUTGR ADR4 are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, CSPC PHARMACEUTGR reported solid returns over the last few months and may actually be approaching a breakup point. ...more
CSPC |
CSPC PHARMACEUTGR Relative Risk vs. Return Landscape
If you would invest 200.00 in CSPC PHARMACEUTGR ADR4 on January 14, 2025 and sell it today you would earn a total of 22.00 from holding CSPC PHARMACEUTGR ADR4 or generate 11.0% return on investment over 90 days. CSPC PHARMACEUTGR ADR4 is generating 0.2761% of daily returns assuming 4.7505% volatility of returns over the 90 days investment horizon. Simply put, 42% of all stocks have less volatile historical return distribution than CSPC PHARMACEUTGR, and 95% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
CSPC PHARMACEUTGR Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CSPC PHARMACEUTGR's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CSPC PHARMACEUTGR ADR4, and traders can use it to determine the average amount a CSPC PHARMACEUTGR's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0581
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CVGU | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.75 actual daily | 42 58% of assets are more volatile |
Expected Return
| 0.28 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average CSPC PHARMACEUTGR is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CSPC PHARMACEUTGR by adding it to a well-diversified portfolio.
CSPC PHARMACEUTGR Fundamentals Growth
CSPC Stock prices reflect investors' perceptions of the future prospects and financial health of CSPC PHARMACEUTGR, and CSPC PHARMACEUTGR fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CSPC Stock performance.
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.22 % | |||
| Shares Outstanding | 2.98 B | |||
| Price To Earning | 18.49 X | |||
| Revenue | 30.72 B | |||
| EBITDA | 7.56 B | |||
| Cash And Equivalents | 9.28 B | |||
| Cash Per Share | 3.10 X | |||
| Total Debt | 316.71 M | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 9.41 X | |||
| Earnings Per Share | 0.25 X | |||
About CSPC PHARMACEUTGR Performance
By analyzing CSPC PHARMACEUTGR's fundamental ratios, stakeholders can gain valuable insights into CSPC PHARMACEUTGR's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CSPC PHARMACEUTGR has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CSPC PHARMACEUTGR has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the Peoples Republic of China, other Asian regions, the Americas, Europe, and internationally. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the Peoples Republic of China. CSPC PHARMACEUT operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 21527 people.Things to note about CSPC PHARMACEUTGR ADR4 performance evaluation
Checking the ongoing alerts about CSPC PHARMACEUTGR for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CSPC PHARMACEUTGR ADR4 help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CSPC PHARMACEUTGR had very high historical volatility over the last 90 days |
- Analyzing CSPC PHARMACEUTGR's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CSPC PHARMACEUTGR's stock is overvalued or undervalued compared to its peers.
- Examining CSPC PHARMACEUTGR's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CSPC PHARMACEUTGR's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CSPC PHARMACEUTGR's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CSPC PHARMACEUTGR's stock. These opinions can provide insight into CSPC PHARMACEUTGR's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CSPC Stock analysis
When running CSPC PHARMACEUTGR's price analysis, check to measure CSPC PHARMACEUTGR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSPC PHARMACEUTGR is operating at the current time. Most of CSPC PHARMACEUTGR's value examination focuses on studying past and present price action to predict the probability of CSPC PHARMACEUTGR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSPC PHARMACEUTGR's price. Additionally, you may evaluate how the addition of CSPC PHARMACEUTGR to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Global Correlations Find global opportunities by holding instruments from different markets |